Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis

Journal of Bacteriology

Volumn 187, Issue 4, 2005, Pages 1324-1333

  Ortega, Ximena ^a   Hunt, Tracey A ^a,e   Loutet, Slade ^a   Vinion Dubiel, Arlene D ^b   Datta, Anup ^c   Choudhury, Biswa ^c   Goldberg, Joanna B ^b   Carlson, Russell ^c,d   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c University of Georgia ^*  (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLTRANSFERASE; LIPID A; LIPOPOLYSACCHARIDE; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE; RHAMNOSE; TRISACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DNA FLANKING REGION; GENE CLUSTER; GENE IDENTIFICATION; GENE INSERTION; LUNG INFECTION; MOLECULAR CLONING; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; TRANSPOSON;

BURKHOLDERIA; BURKHOLDERIA INFECTIONS; COMPLEMENT SYSTEM PROTEINS; CONJUGATION, GENETIC; CYSTIC FIBROSIS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; GLYCOSYLTRANSFERASES; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; MUTAGENESIS, INSERTIONAL; O ANTIGENS; SEQUENCE ANALYSIS, DNA; TRISACCHARIDES; VIRULENCE FACTORS;

EID: 14544282391     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.187.4.1324-1333.2005     Document Type: Article

References (61)

1. Aaron, S. D., W. Ferris, D. A. Henry, D. P. Speert, and N. E. Macdonald. 2000. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am. J. Respir. Crit. Care Med. 161:1206-1212.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Baird, R. M., H. Brown, A. W. Smith, and M. L. Watson. 1999. Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells. Immunopharmacology 44:267-272.
4. Burns, J. L., M. Jonas, E. Y. Chi, D. K. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059.
5. Burtnick, M. N., P. J. Brett, and D. E. Woods. 2002. Molecular and physical characterization of Burkholderia mallei O antigens, J. Bacteriol. 184:849-852.
6. Chen, J. S., K. A. Witzmann, T. Spilker, R. J. Fink, and J. J. LiPuma. 2001. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 139:643-649.
7. Chung, J. W., E. Altman, T. J. Beveridge, and D. P. Speert. 2003. Colonial morphology of Burkholderia cepacia complex genomovar III: Implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect. Immun. 71:904-909.
8. Ciucanu, I., and F. Kerek. 1984. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 131:209-217.
9. Coenye, T., and J. J. LiPuma. 2002. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J. Infect. Dis. 185:1454-1462.
10. Coenye, T., T. Spilker, A. Martin, and J. J. LiPuma. 2002. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J. Clin. Microbiol. 40:3300-3307.
11. Coenye, T., and P. Vandamme. 2003. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ. Microbiol. 5:719-729.
12. Corbett, C. R., M. N. Burtnick, C. Kooi, D. E. Woods, and P. A. Sokol. 2003. An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology 149:2263-2271.
13. Cox, A. D., C. J. Taylor, A. J. Anderson, M. B. Perry, and S. G. Wilkinson. 1995. Structures of the two polymers present in the lipopolysaccharide of Burkholderia (Pseudomonas) cepacia serogroup O4. Eur. J. Biochem. 231:784-789.
14. Craig, F. F., J. G. Coote, R. Parton, J. H. Freer, and N. J. Gilmour. 1989. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J. Gen. Microbiol. 135:2885-2890.
15. Darling, P., M. Chan, A. D. Cox, and P. A. Sokol. 1998. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect. Immun. 66:874-877.
16. Darveau, R. P., and R. E. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838.
17. DeShazer, D., P. J. Brett, and D. E. Woods. 1998. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 30:1081-1100.
18. Devine, D. A. 2003. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol. Immunol. 40:431-443.
19. Evans, E., I. R. Poxton, and J. R. W. Govan. 1999. Lipopolysaccharide chemotypes of Burkholderia cepacia. J. Med. Microbiol. 48:1-8.
20. Feldman, M. F., C. L. Marolda, M. A. Monteiro, M. B. Perry, A. J. Parodi, and M. A. Valvano. 1999. The activity of a putative polyisoprenol-linked sugar translocase(Wzx) involved in Escherichia coli O antigen assembly is independent of the chemical structure of the O repeat. J. Biol. Chem. 274:35129-35138.
21. Figurski, D. H., and B. R. Helinski. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. USA 76:1648-1652.
22. Glisin, V., R. Crkvenjakov, and C. Byus. 1974. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633-2637.
23. Govan, J. R., P. H. Brown, J. Maddison, C. J. Doherty, J. W. Nelson, M. Dodd, A. P. Greening, and A. K. Webb. 1993. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
24. Govan, J. R., J. E. Hughes, and P. Vandamme. 1996. Burkholderia cepacia: Medical, taxonomic and ecological issues. J. Med. Microbiol., 45:395-407.
25. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
26. Heidt, A., H. Monteil, and C. Richard. 1983. O and H serotyping of Pseudomonas cepacia. J. Clin. Microbiol. 18:738-740.
27. Huber, B., K. Riedel, M. Hentzer, A. Heydorn, A. Gotschlich, M. Givskov, S. Molin, and L. Eberl. 2001. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147:2517-2528.
28. Huber, B., K. Riedel, M. Köthe, M. Givskov, S. Molin, and L. Eberl. 2002. Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia Hill. Mol. Microbiol. 46:411-426.
29. Hunt, T. A., C. Kool, P. A. Sokol, and M. A. Valvano. 2004. Identification of Burkholderia cenocepacia (formerly Burkholderia cepacia genomovar III) genes required for bacterial survival in vivo. Infect. Immun. 72:4010-4022.
30. Hutchinson, M. L., I. R. Poxton, and J. R. W. Govan. 1998. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect. Immun. 66:2033-2039.
31. Isles, A., I. Maclusky, M. Corey, R. Gold, C. Prober, P. Fleming, and H. Levison. 1984. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 104:206-210.
32. Isshiki, Y., U. Zahringer, and K. Kawahara. 2003. Structure of the core-oligosaccharide with a characteristic D-glycero-α-D-talo-oct-2- ulosylonate-(2→4)-3-deoxy-D-manno-oct-2-ulo sonate [α-Ko-(2→4)- Kdo] disaccharide in the lipopolysaccharide from Burkholderia cepacia. Carbohydr. Res. 338:2659-2666.
33. Johnson, W. M., S. D. Tyler, and K. R. Rozee. 1994. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J. Clin. Microbiol. 32:924-930.
34. Keig, P. M., E. Ingham, and K. G. Kerr. 2001. Invasion of human type II pneumocytes by Burkholderia cepacia. Microb. Pathog. 30:167-170.
35. Kresse, A. U., S. D. Dinesh, K. Larbig, and U. Römling. 2003. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 47:145-158.
36. Kumar, A., S. Dietrich, W. Schneider, R. Jacobson, F. P. Downes, B. E. Robinson-Dunn, R. Honicky, J. Smith, and R. Martin. 1997. Genetic relatedness of Burkholderia (Pseudomonas) cepacia isolates from five cystic fibrosis centers in Michigan. Respir. Med. 91:485-492.
37. Lamothe, J., S. Thyssen, and M. A. Valvano. 2004. Burkholderia cepacia complex isolates survive intracellularly without replication within acidic vacuoles of acanthamoeba polyphaga. Cell. Microbiol. 6:1127-1138.
38. Lefebre, M. D., and M. A. Valvano. 2001. Catalases and superoxide dismutases in strains of the Burkholderia cepacia complex and their roles in resistance to reactive oxygen species. Microbiology 147:97-109.
39. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
40. Lewenza, S., B. Conway, E. P. Greenberg, and P. A. Sokol. 1999. Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J. Bacteriol. 181:748-756.
41. LiPuma, J. J., T. Spilker, L. H. Gill, P. W. Campbell, L. Liu, and E. Mahenthiralingam. 2001. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164:92-96.
42. Mahenthiralingam, E., T. Coenye, J. W. Chung, D. P. Speert, J. R. Govan, P. Taylor, and P. Vandamme. 2000. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J. Clin. Microbiol. 38:910-913.
43. Marolda, C. L., B. Hauröder, M. A. John, R. Michel, and M. A. Valvano. 1999. Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae. Microbiology 145:1509-1517.
44. Marolda, C. L., J. Welsh, L. Dafoe, and M. A. Valvano. 1990. Genetic analysis of the O7-polysaccharide biosynthesis region from the Escherichia coli O7:K1 strain VW187, J. Bacteriol. 172:3590-3599.
45. Martin, D. W., and C. D. Mohr. 2000. Invasion and intracellular survival of Burkholderia cepacia. Infect. Immun. 68:24-29.
46. Moreira, L. M., P. A. Videira, S. A. Sousa, J. H. Leitao, M. V. Cunha, and I. Sa-Correia. 2003. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem. Biophys. Res. Commun. 312:323-333.
47. Nzula, S., P. Vandamme, and J. R. W. Govan. 2002. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 50:265-269.
48. Raetz, C. R. H., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71:635-700.
49. Rocchetta, H. L., L. L. Burrows, J. C. Pacan, and J. S. Lam. 1998. Three rhamnosyltransferases responsible for assembly of the A-band D- rhamnan polysaccharide in Pseudomonas aeruginosa: a fourth transferase. WbpL, is required for the initiation of both A-band and B-band lipopolysaccharide synthesis. Mol. Microbiol. 28:1103-1119.
50. Rutherford, K., J. Parkhill, J. Crook, T. Horsnell, P. Rice, M.-A. Rajandream, and B. Barrell. 2000. Artemis: sequence visualisation and annotation. Bioinformatics 16:944-945.
51. Salni, L., S. Galsworthy, M. John, and M. A. Valvano. 1999. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145:3465-3475.
52. Sajjan, U. S., L. Sun, R. Goldstein, and J. F. Forstner. 1995. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177:1030-1038.
53. Schägger, H., and G. von Jagow. 1987, Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
54. Speert, D. P., D. Henry., P. Vandamme, M. Corey, and E. Mahenthiralingam. 2002. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis. 8:181-187.
55. Tablan, O. C., T. L. Chroba, D. V. Schidlow, J. W. White, K. A. Hardy, P. H. Giligan, W. M. Morgan, L. A. Chow, W. J. Martone, and W. R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J. Pediatr. 107:382-387.
56. Tomich, M., A. Griffith, C. A. Herfst, J. L. Burns, and C. D. Mohr. 2003. Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect. Immun. 71:1405-1415.
57. Tomich, M., C. A. Herfst, J. W. Golden, and C. D. Mohr. 2002. Role of flagella in host cell invasion by Burkholderia cepacia. Infect. Immun. 70:1799-1806.
58. Valvano, M. A. 2003. Export of O-specific lipopolysaccharide. Front. Biosci. 8:S452-S471.
59. Vasil, M. L., D. P. Krieg, J. S. Kuhns, J. W. Ogle, V. D. Shortridge, R. M. Ostroff, and A. I. Vasil. 1990. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect. Immun. 58:4020-4029.
60. York, W. S., A. G. Darvill, M. McNeil, T. T. Stevenson, and P. Albersheim. 1985. Isolation and characterization of plant cell walls and cell-wall components. Methods Enzymol. 118:3-40.
61. Zughaler, S. M., H. C. Ryley, and S. K. Jackson. 1999. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocytic respiratory burst activity by scavenging superoxide anion. Infect. Immun. 67:908-913.